NolphK.D.Update on peritoneal dialysis.Worldwide Registry Update Baxter Healthcare Inc, Deerfield II, USA, 1996.
2.
OreopoulosD.G., BargmanJ.M., KhannaR.Experiences with long-term peritoneal dialysis. Workshop, 16th Annual Conference on Peritoneal Dialysis, Seattle, Washington, 1996.
3.
MaiorcaR., CancariniG., BrunoriR.Which treatment for which patient in the future? Possible modification in CAPD. Nephrol Dial Transplant1995; 10: 20–6.
4.
GokalR., TakubowskiC., KingJ.Outcome in patients on continuous ambulatory peritoneal dialysis and hemodialysis: 4 year analysis of a prospective multicenter study. Lancet1987; 2: 1105–9.
5.
MaiorcaR., CancariniG.C., BrunoriG.Morbidity and mortality of CAPD and hemodialysis. Kidney Int1993; 43 (suppl): S4–15.
OreopoulosD.G., VasS., KhannaR.Prevention of peritonitis during continuous ambulatory peritoneal dialysis. Perit Dial Bull1983; 3 (suppl): S18–20.
8.
KeaneW.F., VasS.I.Peritonitis. In: GokalR., NolphK.D., eds. The textbook of peritoneal dialysis.The Netherlands: Kluwer Academic Publishers, 1994: 473–501.
9.
DigenisG.E., AbrahamG., SavinE.Peritonitis related deaths in continuous ambulatory peritoneal dialysis patients. Perit Dial Int1990; 10: 45–7.
10.
ColesG.A.Mupirocin study group. The effect of intranasal mupirocin on CAPD exit-site infection. J Am Soc Nephrol1994; 5: 439–42.
11.
BernardiniJ., LutesR., JohnstonJ.R., HolleyJ.L., PirainoB.Randomized trial of rifampin versus mupirocin to prevent S. aureus infections in PD patients (Abstract). Perit Dial Int1995; 15 (suppl): S17.
12.
GotchF., SargentJ.A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int1985; 28: 526–34.
13.
TeehanB.P., SchleiferC., SiglerM., GilgoreG.A quantitative approach to the CAPD prescription. Perit Dial Bull1985; 5: 152–6.
14.
ChurchillD.N., TaylorD.W., KeshaviahP.R.Canada-USA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis. Association with clinical outcomes. J Am Soc Nephrol1996; 7: 198–207.
15.
LiberekT., TopleyN., JorresA.Peritoneal dialysis fluid inhibition of phagocyte function: effect of osmolality and glucose concentration. J Am Soc Nephrol1993; 3: 1508–15.
BreborowiczA., OreopoulosD.G.Physiological approaches to increase biocompatibility of peritoneal dialysis. Perit Dial Int1995; 15 (suppl): S76–86.
19.
YoungG.A., KoppleJ.D., LindholmB.Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis1991; 27: 462–71.
20.
DesmeulesM., ShanbelD., FentonS.S.A.Hemodialysis vs continuous ambulatory peritoneal dialysis: a comparison of patient survival among recently diagnosed Canadians (Abstract). Perit Dial Int1996; 16.
21.
BloembergenW.E., PortF.K., MaugerE.A., WolfeR.A.A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol1995; 6: 184–91.
